Abstract

Radioisotope 99 Mo is one of the most essential radioisotopes in nuclear medicine. Its production in an Aqueous Homogeneous Reactor (AHR) could be potentially advantageous compared to the traditional technology, based on target irradiation in a heterogeneous reactor. An AHR conceptual design using low-enriched uranium for the production of 99 Mo has been studied in depth. So far, the possibility of replacing uranium with a non-uranium fuel, specifically a mixture of 232 Th and 233 U, has not been evaluated in the conceptual design. Therefore, the studies conducted in this article aim to evaluate the neutronic behavior of the AHR conceptual design using thorium sulfate solution. Here, the 232 Th- 233 U composition to guarantee ten years of operation without refueling, conversion ratio, medical isotopes production levels, and reactor kinetic parameters were evaluated, using the computational code MCNP6. It was obtained that 14 % 233 U enrichment guarantees the reactor operation for ten years without refueling. The conversion ratio was calculated at 0.14. The calculated 99 Mo production in the AHR conceptual design resulted in 24.4 % higher with uranium fuel than with thorium fuel.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.